Patient conditions of non-inflammatory degenerative joint disease (NIDJ): avascular necrosis, osteoarthritis, ankylosis, protrusio acetabuli and painful hip dysplasia.
Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis.
Those patients with failed previous surgery where pain, deformity, or dysfunction persists.
Revision of a previously failed hip arthroplasty.
Patients who require a total hip replacement.

Device Description

The Klassic HD® Hip System employs prostheses designed to help surgeons restore hip joint biomechanics intra-operatively. The purpose of this Special 510(k) is to add smaller sizes of the Acetabular Cups, Acetabular Inserts, and Ceramic Femoral Heads and to add both smaller and predicate sizes of Hooded and Low Profile Acetabular Inserts with XLPE material.

AI/ML Overview

This document is a 510(k) Summary for the Klassic HD® Hip System, a medical device for hip replacement. It generally outlines the device's indications for use, description, predicate devices, and a statement of substantial equivalence to previously cleared devices.

However, the document does not describe the acceptance criteria and the study that proves the device meets the acceptance criteria in the way requested in the prompt. It states that "all results met the pre-determined acceptance criteria identified in the Design Control Activities" and that the "information summarized in the Design Control Activities Summary demonstrates that the modified Klassic HD® Hip System met the pre-determined acceptance criteria for the verification activities." It also lists the types of testing performed (e.g., burst strength testing, fatigue testing, wear testing, etc.) and the relevant ISO and ASTM standards.

Crucially, the document explicitly says that the details of the acceptance criteria and the study results are "summarized in the Design Control Activities Summary," which is not provided in the input text.

Therefore, I cannot provide the specific details requested in your prompt based solely on the provided text. The document acts as a summary and refers to another internal document for the detailed evidence of compliance.

Key Missing Information:

Specific Acceptance Criteria: The document mentions "pre-determined acceptance criteria" but does not list them.
Reported Device Performance: While it states the device "met" the criteria, the actual performance values are not provided.
Sample Sizes: No sample sizes are mentioned for any of the tests.
Data Provenance: No information on the origin of data (country, retrospective/prospective).
Experts/Ground Truth: This type of medical device (hip implant) does not typically involve "experts establishing ground truth" in the diagnostic AI sense. Its acceptance criteria relate to mechanical and material performance, not diagnostic accuracy. Therefore, questions about expert numbers, qualifications, adjudication methods, MRMC studies, standalone performance, and ground truth types are not applicable in this context.
Training Set Sample Size/Ground Truth: Not applicable for this type of device.

What the document does state regarding testing:

Engineering analysis and testing included: burst strength testing, fatigue testing, post-fatigue burst strength testing, pull-off testing of ceramic femoral heads (per ISO 7206-10), push-out, lever-out, axial torque disassembly (per ASTM F1820), Range of Motion (per ISO 21535), impingement testing (per ASTM F2852), and wear testing (per ISO 14242).
LAL testing requirements: The device is in compliance with LAL testing requirements for orthopedic implants per AAMI ST-72.
Conclusion: "all results met the pre-determined acceptance criteria identified in the Design Control Activities."

In summary, while the document confirms that testing was done and acceptance criteria were met, it does not provide the details of those criteria or the results, stating they are in the "Design Control Activities Summary."

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the U.S. Food & Drug Administration (FDA). The Department of Health & Human Services logo is on the left, featuring a stylized human figure. To the right of it is the FDA logo, with the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in a larger, bolder font, and "ADMINISTRATION" in a smaller font below.

Total Joint Orthopedics, Inc. Mr. Chris Weaber Product Development, Regulatory Manager 1567 E. Stratford Avenue Salt Lake City, Utah 84106

May 9, 2018

Re: K180929

Trade/Device Name: Klassic HD® Hip System Regulation Number: 21 CFR 888.3353 Regulation Name: Hip Joint Metal/Ceramic/Polymer Semi-Constrained Cemented Or Nonporous Uncemented Prosthesis Regulatory Class: Class II Product Code: LZO, LPH, OOG, MBL, LWJ Dated: April 9, 2018 Received: April 9, 2018

Dear Mr. Chris Weaber:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K180929

Device Name Klassic HD® Hip System

Indications for Use (Describe)
The Klassic HD Hip System is intended for...

The Klassic HD Hip System is intended for prosthetic replacement without bone cement in treatment of the following: · Patient conditions of non-inflammatory degenerative joint disease (NIDJ): avascular necrosis, osteoarthritis, ankylosis, protrusio acetabuli and painful hip dysplasia.
· Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis.
· Those patients with failed previous surgery where pain, deformity, or dysfunction persists.
· Revision of a previously failed hip arthroplasty.
· Patients who require a total hip replacement.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary

Manufacturer:	Total Joint Orthopedics, Inc.1567 E. Stratford AvenueSalt Lake City, UT 84106Phone: 801.486.6070Fax: 801.486.6117
Contact:	Mr. Chris WeaberProduct Development, Regulatory Manager
Prepared By:	Musculoskeletal Clinical Regulatory Advisers, LLC1050 K Street, NW, Suite 1000Washington, DC 20001Phone: 202.552.5800Fax: 202.552.5798
Date Prepared:	May 08, 2018
Device Trade Name:	Klassic HD® Hip System
Common Name:	Acetabular Shell, Acetabular Insert, Ceramic Femoral Head
Classifications:	21 CFR 888.3353 - Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis21 CFR 888.3358 - Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis21 CFR 888.3360 - Hip joint femoral (hemi-hip) metalliccemented or uncemented prosthesis.Class II
Product Codes:	LZO, LPH, OQG, MBL, LWJ

Indications for Use:

The Klassic HD® Hip System is intended for prosthetic replacement without bone cement in treatment of the following:

. Patient conditions of non-inflammatory degenerative joint disease (NIDJD): avascular necrosis, osteoarthritis, ankylosis, protrusio acetabuli and painful hip dysplasia.
Patient conditions of inflammatory joint disease (IJD): rheumatoid arthritis. ●

{4}------------------------------------------------

Those patients with failed previous surgery where pain, deformity, or dysfunction persists.
Revision of a previously failed hip arthroplasty. ●
Patients who require a total hip replacement.

Device Description:

Predicate Devices:

The modified Klassic HD® Hip System is substantially equivalent to the predicate Klassic HD® Hip System Acetabular Cups with Ti-Coat (K100445), Klassic HD® Acetabular Inserts with E-Link® Poly (K141972), Klassic HD® Acetabular Inserts with XLPE (K161073), Klassic HD® Ceramic Femoral Heads (K143407) and the Klassic HD® Hooded and Low Profile Acetabular Inserts with E-Link® Poly (K173104) with respect to indications, design, materials and function.

Substantial Equivalence:

Engineering analysis and testing included burst strength testing, fatigue testing, postfatigue burst strength testing and pull off testing of ceramic femoral heads per ISO 7206-10. Analysis and testing also included Push out, lever out, axial torque disassembly per ASTM F1820, Range of Motion per ISO 21535, impingement testing per ASTM F2852 and wear testing per ISO 14242. and all results met the pre-determined acceptance criteria identified in the Design Control Activities. The information summarized in the Design Control Activities Summary demonstrates that the modified Klassic HD® Hip System met the pre-determined acceptance criteria for the verification activities. Additionally, the Klassic HD® Hip System is in compliance with LAL testing requirements for orthopedic implants per AAMI ST-72 testing.

Regulation Number and Section

§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.

(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.